CJC-1295 with  DACCD2

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

CJC-1295 with DAC

GH and IGF-I secretion

CJC-1295 with DAC specifications and reference prices. Select a specification to add it to your cart.

2mg/vial x 10vials
Reference priceUS$200

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
CD22mg/vial x 10vialsUS$200
CD55mg/vial x 10vialsUS$384.85
CD1010mg/vial x 10vialsUS$593.94

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related data on GH and IGF-I secretion of CJC-1295 with DAC. First, look at the research questions and findings, then check the population or species, study formulations, and scope of interpretation.

Main TopicsGH · IGF-I Secretion
USAGE REFERENCE

CJC-1295 (with DAC) · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
Reference dosageCommonly used 1mg/week or divided doses; long-acting

🔁Cycle

Subcutaneous injection 1–2 times per week.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings does CJC-1295 with DAC have regarding GH and IGF-I secretion?

GH and IGF-I increase while retaining pulsatile secretion characteristics. Other studies report: daily administration brings growth and body composition close to normal.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
3 Main ReferencesSorted by First Publication Date ↓
Human Study2006 · Historical basic researchREF. 01

Does GH pulsatility persist with long-acting stimulation?

Research Findings

GH and IGF-I increase while retaining pulsatile secretion characteristics.[1] ↗

Study Design

Endocrine study in healthy males before and after dosing

Scope & Limitations

2006; Small sample physiological study.

View the Article Title and Full Citation+

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.

Ionescu M, Frohman LA.

The Journal of Clinical Endocrinology and Metabolism · Volume, Issue, Year 2006
First published 2006-10-03 · PMID 17018654
DOI 10.1210/jc.2006-1702

Animal Study2006 · Historical basic researchREF. 02

What findings are there on growth models in GHRH-deficient mice?

Research Findings

Daily dosing brings growth and body composition close to normal.[2] ↗

Study Design

GHRH knockout mice

Scope & Limitations

2006 disease model; cannot be applied to non-DAC products or healthy adults.

View the Article Title and Full Citation+

Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.

Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R.

American Journal of Physiology. Endocrinology and Metabolism · Volume and Year 2006
First published 2006-07-05 · PMID 16822960
DOI 10.1152/ajpendo.00201.2006

Human Study2006 · Historical basic researchREF. 03

How does the long-acting CJC-1295 human hormone respond?

Research Findings

CJC-1295 maintained increases in GH and IGF-I for a longer period.[3] ↗

Study Design

Healthy adult placebo-controlled study

Scope & Limitations

2006; Hormone indicators are not clinical functional benefits and only apply to long-acting DAC forms.

View the Article Title and Full Citation+

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA.

The Journal of Clinical Endocrinology and Metabolism · Volume, Issue, Year 2006
First published 2005-12-13 · PMID 16352683
DOI 10.1210/jc.2005-1536

i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

CJC-1295 with DAC · Frequently Asked Questions.

What research findings does CJC-1295 with DAC have regarding GH and IGF-I secretion?+

GH and IGF-I increase while retaining pulsatile secretion characteristics. Other studies report: daily administration brings growth and body composition close to normal.[1] ↗ [2] ↗

In the CJC-1295 with DAC study, what does the GH increase represent?+

Explains that Certain Long-Acting Forms Have Physiological Effects on the GH/IGF-I Axis. Short-Term Hormonal Changes Do Not Equate to Proven Muscle Growth, Athletic Performance, or Anti-Aging, and Cannot Be Applied to Non-DAC Forms.[3] ↗ [1] ↗

CJC-1295 with DAC—these conclusions apply to which study populations?+

Endocrine study in healthy males before and after dosing; GHRH knockout mice; healthy adult placebo-controlled study. 2006; small sample physiological study.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp